Skip to main content
Year archive

HLB PHARMACEUTICAL CO., LTD. — 2021 filings

All 43 regulatory filings released by HLB PHARMACEUTICAL CO., LTD. (047920) in 2021, sourced directly from the official regulator.

43 Filings
2021 Period
2021 filings (43)
Filing Released Lang
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-12-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-12-29 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2021-12-14 Korean
전환가액의조정
Share Issue/Capital Change
2021-12-13 Korean
[기재정정]분기보고서 (2021.09)
Interim / Quarterly Report 9M 2021
2021-11-16 Korean
분기보고서 (2021.09)
Interim / Quarterly Report 9M 2021
2021-11-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-10-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-10-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-10-25 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-10-25 Korean
전환청구권행사
Share Issue/Capital Change
2021-10-21 Korean
전환청구권행사
Share Issue/Capital Change
2021-10-20 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-09-24 Korean
반기보고서 (2021.06)
Interim / Quarterly Report H1 2021
2021-08-13 Korean
전환가액의조정
Capital/Financing Update
2021-06-14 Korean
[기재정정]사업보고서 (2020.12)
Regulatory Filings FY 2020
2021-06-01 Korean
[기재정정]분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-06-01 Korean
[기재정정]분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-05-18 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-05-14 Korean
[기재정정]타법인주식및출자증권취득결정
M&A Activity
2021-04-12 Korean
기타경영사항(특허권취득)(자율공시)(도네페질 함유 서방출성 PLGA 미립구의 제조방법)
Regulatory Filings
2021-04-02 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2021-03-30 Korean
타법인주식및출자증권취득결정
M&A Activity
2021-03-29 Korean
[기재정정]사업보고서 (2020.12)
Audit Report / Information FY 2020
2021-03-23 Korean
감사보고서제출
Audit Report / Information FY 2020
2021-03-22 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2020
2021-03-22 Korean
파생상품거래손실발생
Capital/Financing Update
2021-03-22 Korean
[기재정정]주주총회소집공고
AGM Information
2021-03-22 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2021-03-22 Korean
사업보고서 (2020.12)
Annual Report FY 2020
2021-03-22 Korean
증권발행결과(자율공시)
Capital/Financing Update
2021-03-12 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2021-03-12 Korean
주주총회소집공고
AGM Information
2021-03-12 Korean
주주총회소집결의
AGM Information
2021-02-26 Korean
주주총회집중일개최사유신고
AGM Information
2021-02-26 Korean
주요사항보고서(유형자산양수결정)
M&A Activity
2021-02-16 Korean
합병등종료보고서(자산양수도)
M&A Activity
2021-02-16 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2021-02-10 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2020
2021-02-03 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2020
2021-02-02 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-01-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-01-27 Korean
기타경영사항(특허권취득)(자율공시)(리바스티그민(치매치료제)의 일정한(0-차) 방출형 경구용 서방성 정제 조성물)
Regulatory Filings
2021-01-25 Korean